查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球生物與醫學成像試劑市場
市場調查報告書
商品編碼
1813340

全球生物與醫學成像試劑市場

Biological and Medical Imaging Reagents: Global Markets
出版日期: | 出版商: BCC Research | 英文 192 Pages | 訂單完成後即時交付

價格

全球生物和醫學影像試劑市場預計將從2025年的266億美元成長到2030年底的401億美元，2025年至2030年期間的年複合成長率為 8.6%。

預計北美生物和醫學成像試劑市場在2025年至2030年間將以 9.0%的年複合成長率成長，從2025年的113億美元成長到2030年底的174億美元。

亞太地區生物和醫學影像試劑市場規模預計將從2025年的55億美元成長到2030年底的86億美元，2025年至2030年的年複合成長率為 9.8%。

調查範圍

本報告調查生物和醫學成像試劑市場，並分析了市場趨勢。報告以2024年為基準年，提供全球收益（百萬美元），並預測2025年至2030年的成長情況。市場根據類型、模式、技術、應用、最終用戶和地區進行細分。研究涵蓋北美、歐洲、亞太、中東和非洲以及南美，並重點關注這些地區的主要國家。

本報告重點介紹了影響市場和供應商格局的主要驅動趨勢和新興技術，分析了環境、社會和治理（ESG）發展，並討論了與市場相關的專利和新興技術。

報告最後進行了競爭格局分析，提供了全球主要生物和醫學成像試劑公司的排名/佔有率。報告還包括專門的公司簡介章節，涵蓋了市場主要企業的簡介。

報告內容

  • 109個資料表和 68個附加表
  • 全球生物及醫療圖像試劑市場概況
  • 全球市場趨勢分析，包括2022年至2024年的資料、2025年的估計和預測以及預計到2030年的年複合成長率（CAGR）
  • 評估專業生物和醫療圖像試劑的當前市場規模和收益成長前景，並依產品類型、模式、技術、應用、最終用途和地區分析市場佔有率
  • 這些診斷方法的分類、比較、優點、缺點，分析全球生物和醫學影像診斷劑產業的當前和未來需求，以及對競爭格局、市場法規和償付實踐的詳細分析
  • 相關專利分析，重點在於新興技術和新發展
  • 產業 ESG 議題與實務的考量
  • 行業主要企業的市場佔有率分析，以及他們的專有技術、策略聯盟和其他關鍵市場策略的分析
  • 主要企業簡介，包括GE HealthCare、Thermo Fisher Scientific、Siemens Healthineers AG、Bayer AG、Becton, Dickinson and Co.（BD）

目錄

第1章 執行摘要

第2章 市場概況

  • 概述
  • 產業成長動力
  • 波特五力分析
  • 宏觀經濟因素分析
  • 治療診斷學需求
  • 基於影像的侵入性和非侵入性手術
  • 慢性病的流行和投資的增加
  • 藥物發現和其他研發活動
  • 多功能試劑的開發
  • 用更安全的試劑取代有毒有害檢測試劑
  • 創投
  • 美國關稅的影響

第3章 市場動態

  • 概述
  • 市場促進因素
  • 增加研發投入
  • 慢性病增多
  • 治療診斷學和個人化醫療正得到越來越廣泛的應用
  • 用更安全的替代品取代有毒試劑
  • 市場限制
  • 開發和商業化成本高
  • 監管和償付挑戰
  • 市場機會
  • AI在生醫研發及醫療圖像試劑領域的應用
  • 多功能成像劑的出現
  • 市場挑戰
  • 安全問題
  • 保存期限短和穩定性問題

第4章 監理現狀

  • 各國/地區的監管核准流程
  • 美國
  • 歐洲聯盟
  • 亞太地區

第5章 新興技術與發展

  • 關鍵要點
  • 奈米粒子
  • 用於單細胞和蛋白質組學應用的下一代成像試劑
  • 生物和醫學成像試劑中的人工智慧和機器學習
  • 利用近紅外線技術進行創新的橫向流動化驗
  • 螢光染料和混合靶向平台
  • 新型放射性示蹤劑可提高腫瘤學診斷的準確性
  • 專利分析
  • 主要調查結果

第6章 市場區隔分析

  • 細分市場
  • 依產品類型進行市場分析
  • 關鍵要點
  • 顯影劑
  • 放射性試劑
  • 光學試劑
  • 依模式進行市場分析
  • 關鍵要點
  • 光學成像試劑
  • X光/CT試劑
  • 核子造影試劑
  • MRI成像試劑
  • 多模態成像試劑
  • 超音波成像試劑
  • 依技術進行市場分析
  • 關鍵要點
  • 量子點
  • 放射性藥物
  • 螢光蛋白
  • 螢光染料和探針
  • 奈米粒子
  • 依應用進行市場分析
  • 關鍵要點
  • 體內成像試劑
  • 體外成像試劑
  • 依最終用途進行市場分析
  • 關鍵要點
  • 診斷
  • 研究與開發
  • 區域分佈
  • 區域市場分析
  • 關鍵要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第7章 競爭訊息

  • 關鍵要點
  • 主要企業全球市場佔有率
  • 關鍵發展和策略
  • 夥伴關係與合作
  • 獲得
  • 業務擴展
  • 產品發布和FDA核准

第8章 生物和醫學成像試劑市場的永續性：ESG視角

第9章 附錄

  • 調查方法
  • 簡稱
  • 來源
  • 公司簡介
  • AGILENT TECHNOLOGIES INC.
  • ALTONA DIAGNOSTICS GMBH
  • ANALYTIK JENA GMBH+CO. KG.
  • BAYER AG
  • BD
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
  • 一些Start-Ups創公司/市場顛覆者
Product Code: HLC040F

The global market for biological and medical imaging reagents is estimated to grow from $26.6 billion in 2025 and forecast to reach $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

The North American market for biological and medical imaging reagents is estimated to grow from $11.3 billion in 2025 and forecast to reach $17.4 billion by the end of 2030, at a CAGR of 9.0% from 2025 to 2030.

The Asia-Pacific market for biological and medical imaging reagents is estimated to grow from $5.5 billion in 2025 and forecast to reach $8.6 billion by the end of 2030, at a CAGR of 9.8% from 2025 to 2030.

Report Scope

The report provides an overview of the global biological and medical imaging reagent market and analyzes market trends. It includes global revenue ($ millions) using 2024 as the base year, and the forecast from 2025 through 2030. The market is segmented based on type, modality, technology, application end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on major countries in these regions.

The report focuses on the significant driving trends and emerging technologies that influence the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global biological and medical imaging reagent companies. It also has a dedicated section of company profiles covering the profiles of leading companies in the market.

Report Includes

  • 109 data tables and 68 additional tables
  • An overview of the global market for biological and medical imaging reagents
  • Analyses of the global market trends, with data from 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the biologic and medical imaging reagents, accompanied by a market share analysis by product type, modality, technology, application, end use, and region
  • A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods, and analysis of current and future demand in the global biologic and medical imaging reagents industry, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • A relevant patent analysis with emphasis on emerging technologies and new developments
  • A discussion on ESG challenges and practices of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of the leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG and Becton, Dickinson and Co. (BD)

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of the Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Forces Driving Industry Growth
  • Porter's Five Forces Analysis
  • Potential for New Entrants (Moderate to High)
  • Bargaining Power of Suppliers (Moderate)
  • Bargaining Power of Buyers (Moderate)
  • Threat of Substitutes (Low to Moderate)
  • Industry Competition (High)
  • Macroeconomic Factors Analysis
  • Demand for Theranostics
  • Image-based Invasive and Noninvasive Procedures
  • Prevalence of Chronic Diseases and Rising Investments
  • Drug Discovery and Other R&D Activities
  • Development of Multifunctional Reagent Capabilities
  • Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
  • VC Investment
  • Impact of U.S. Tariff

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Increasing Investments in R&D
  • Growing Prevalence of Chronic Diseases
  • Rising Adoption of Theranostics and Personalized Medicine
  • Replacement of Toxic Reagents with Safer Alternatives
  • Market Restraints
  • High Development and Commercialization Costs
  • Regulatory and Reimbursement Challenges
  • Market Opportunities
  • Integration of AI in Biologics R&D and Medical Imaging Reagents
  • Emergence of Multifunctional Imaging Reagents
  • Market Challenges
  • Safety Concerns
  • Short Shelf Life and Stability Issues

Chapter 4 Regulatory Landscape

  • Regulatory Approval Process, by Select Country/Region
  • U.S.
  • European Union
  • Asia-Pacific

Chapter 5 Emerging Technologies and Developments

  • Key Takeaways
  • Nanoparticles
  • Next-Generation Imaging Reagents for Single-Cell and Proteomic Applications
  • AI and ML in Biological and Medical Imaging Reagents
  • Innovative Lateral Flow Assays Enhanced by NIR Technology
  • Fluorochromes and Hybrid Targeting Platforms
  • Emerging Radiotracers Enhancing Diagnostic Accuracy in Oncology
  • Patent Analysis
  • Key Findings

Chapter 6 Market Segment Analysis

  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Key Takeaways
  • Contrast Reagents
  • Radioactive Reagents
  • Optical Reagents
  • Market Analysis by Modality
  • Key Takeaways
  • Optical Imaging Reagents
  • X-ray/CT Reagents
  • Nuclear Imaging Reagents
  • MRI Imaging Reagents
  • Multimodal Imaging Reagents
  • Ultrasound Imaging Reagents
  • Market Analysis by Technology
  • Key Takeaways
  • Quantum Dots
  • Radiopharmaceuticals
  • Fluorescent Proteins
  • Fluorescent Dyes and Probes
  • Nanoparticles
  • Market Analysis by Application
  • Key Takeaways
  • In Vivo Imaging Reagents
  • In Vitro Imaging Reagents
  • Market Analysis by End Use
  • Key Takeaways
  • Diagnostics
  • R&D
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Global Market Shares of Leading Companies
  • Key Developments and Strategies
  • Partnerships and Collaborations
  • Acquisitions
  • Business Expansions
  • Product Launches and FDA Approvals

Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective

  • Introduction to ESG
  • Steps Toward Sustainable Use of Biologics and Medical Imaging Reagents
  • Major Manufacturers: ESG Efforts
  • ESG Risk Ratings
  • Concluding Remarks from BCC

Chapter 9 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • ALTONA DIAGNOSTICS GMBH
  • ANALYTIK JENA GMBH+CO. KG.
  • BAYER AG
  • BD
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • GE HEALTHCARE
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
  • Few Emerging Start-ups/Market Disruptors

List of Tables

  • Summary Table : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
  • Table 1 : Biological Imaging Reagents: Forces Driving Growth
  • Table 2 : Porter's Five Forces: Rating Scale
  • Table 3 : Current and Future Invasive and Noninvasive Imaging Technologies
  • Table 4 : Life Cycle Stage of Biological Imaging Reagents
  • Table 5 : Pharmaceutical R&D Expenditure in Selected Countries, 2023
  • Table 6 : Incidence and Mortality Rates of Cancer Across Regions, 2022
  • Table 7 : Nanoparticles in Imaging Applications
  • Table 8 : Select Published Patents on Biological and Medical Imaging Reagents, May 2025
  • Table 9 : Global Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 10 : Global Market for Contrast Reagents, by Region, Through 2030
  • Table 11 : Global Market for Radioactive Reagents, by Region, Through 2030
  • Table 12 : Global Market for Optical Reagents, by Region, Through 2030
  • Table 13 : Global Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 14 : Global Market for Optical Imaging Reagents, by Region, Through 2030
  • Table 15 : Global Market for X-ray/CT Imaging Reagents, by Region, Through 2030
  • Table 16 : Global Market for Nuclear Imaging Reagents, by Region, Through 2030
  • Table 17 : Key Brands of Gd-Based Contrast Reagents Worldwide
  • Table 18 : Global Market for MRI Imaging Reagents, by Region, Through 2030
  • Table 19 : Global Market for Multimodal Imaging Reagents, by Region, Through 2030
  • Table 20 : Global Market for Ultrasound Imaging Reagents, by Region, Through 2030
  • Table 21 : Global Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 22 : Biological Imaging Applications of QDs
  • Table 23 : Global Market for QDs Technology-based Imaging Reagents, by Region, Through 2030
  • Table 24 : Global Market for Radiopharmaceuticals Technology-based Imaging Reagents, by Region, Through 2030
  • Table 25 : Types of FPs
  • Table 26 : Global Market for FPs Technology-based Imaging Reagents, by Region, Through 2030
  • Table 27 : Fluorescent Dyes and Probes
  • Table 28 : Global Market for Fluorescent Dyes and Probes Technology-based Imaging Reagents, by Region, Through 2030
  • Table 29 : Global Market for Nanoparticle Technology-based Imaging Reagents, by Region, Through 2030
  • Table 30 : Global Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 31 : Biological Imaging Reagents Applications
  • Table 32 : Global Market for In Vivo Imaging Reagents, by Region, Through 2030
  • Table 33 : Significance of Medical Imaging Reagents to the Life Sciences and Medical Industries
  • Table 34 : Global Market for In Vitro Imaging Reagents, by Region, Through 2030
  • Table 35 : Global Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 36 : Global Market for Diagnostics Imaging Reagents, by Region, Through 2030
  • Table 37 : Global Market for R&D Imaging Reagents, by Region, Through 2030
  • Table 38 : Global Market for Biological and Medical Imaging Reagents, by Region, Through 2030
  • Table 39 : North American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 40 : North American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 41 : North American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 42 : North American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 43 : North American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 44 : North American Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 45 : U.S. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 46 : U.S. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 47 : U.S. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 48 : Canadian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 49 : Canadian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 50 : Canadian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 51 : Mexican Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 52 : Mexican Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 53 : Mexican Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 54 : European Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 55 : European Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 56 : European Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 57 : European Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 58 : European Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 59 : European Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 60 : U.K. Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 61 : U.K. Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 62 : U.K. Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 63 : French Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 64 : French Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 65 : French Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 66 : Italian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 67 : Italian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 68 : Italian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 69 : German Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 70 : German Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 71 : German Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 72 : Spanish Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 73 : Spanish Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 74 : Spanish Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 75 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 76 : Rest of Europe Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 77 : Rest of Europe Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 78 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 79 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 80 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 81 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 82 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 83 : Asia-Pacific Market for Biological and Medical Imaging Reagents, by Country, Through 2030
  • Table 84 : Chinese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 85 : Chinese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 86 : Chinese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 87 : Indian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 88 : Indian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 89 : Indian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 90 : Japanese Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 91 : Japanese Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 92 : Japanese Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 93 : Australian Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 94 : Australian Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 95 : Australian Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 96 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 97 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 98 : Rest of Asia-Pacific Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 99 : South American Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 100 : South American Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 101 : South American Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 102 : South American Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 103 : South American Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 104 : MEA Market for Biological and Medical Imaging Reagents, by Product Type, Through 2030
  • Table 105 : MEA Market for Biological and Medical Imaging Reagents, by Modality, Through 2030
  • Table 106 : MEA Market for Biological and Medical Imaging Reagents, by Technology, Through 2030
  • Table 107 : MEA Market for Biological and Medical Imaging Reagents, by Application, Through 2030
  • Table 108 : MEA Market for Biological and Medical Imaging Reagents, by End Use, Through 2030
  • Table 109 : Leading Manufacturers in the Biological and Medical Imaging Reagent Market, 2024
  • Table 110 : Collaborations and Partnerships: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 111 : Acquisition: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 112 : Business Expansion Activities: Biological and Medical Imaging Reagents Market, 2023-2025
  • Table 113 : Product Launches and FDA Approval Activities: Biological and Medical Imaging Reagents Market, 2022-2025
  • Table 114 : Examples of Current Imaging Agents and Their Potential Concerns
  • Table 115 : ESG Highlights, by Major Players, 2024
  • Table 116 : ESG Risk Rankings for Biological and Medical Imaging Reagents Market, by Manufacturing Companies, 2024
  • Table 117 : Abbreviations Used in This Report
  • Table 118 : Report Information Sources
  • Table 119 : Agilent Technologies Inc.: Company Snapshot
  • Table 120 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
  • Table 121 : Agilent Technologies Inc.: Product Portfolio
  • Table 122 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
  • Table 123 : Altona Diagnostic GmbH.: Company Snapshot
  • Table 124 : Altona Diagnostic GmbH.: Product Portfolio
  • Table 125 : Altona Diagnostic GmbH: News/Key Developments, 2022-2025
  • Table 126 : Analytik Jena GmbH+Co. KG: Company Snapshot
  • Table 127 : Analytik Jena GmbH+Co. KG: Product Portfolio
  • Table 128 : Analytik Jena GmbH+Co. KG: News/Key Developments, 2023 and 2024
  • Table 129 : Bayer AG: Company Snapshot
  • Table 130 : Bayer AG: Financial Performance, FY 2023 and 2024
  • Table 131 : Bayer AG: Product Portfolio
  • Table 132 : Bayer AG: News/Key Developments, 2024 and 2025
  • Table 133 : BD: Company Snapshot
  • Table 134 : BD: Financial Performance, FY 2023 and 2024
  • Table 135 : BD: Product Portfolio
  • Table 136 : BD: News/Key Developments, 2022-2024
  • Table 137 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 138 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
  • Table 139 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 140 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2025
  • Table 141 : Danaher Corp.: Company Snapshot
  • Table 142 : Danaher Corp.: Financial Performance, FY 2023 and 2024
  • Table 143 : Danaher Corp.: Product Portfolio
  • Table 144 : Danaher Corp.: News/Key Developments, 2021-2023
  • Table 145 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 146 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
  • Table 147 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 148 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023 and 2024
  • Table 149 : GE HealthCare: Company Snapshot
  • Table 150 : GE HealthCare: Financial Performance, FY 2023 and 2024
  • Table 151 : GE HealthCare: Product Portfolio
  • Table 152 : GE HealthCare: News/Key Developments, 2024 and 2025
  • Table 153 : Merck KGaA: Company Snapshot
  • Table 154 : Merck KGaA: Financial Performance, FY 2023 and 2024
  • Table 155 : Merck KGaA.: Product Portfolio
  • Table 156 : Merck KGaA: News/Key Developments, 2022-2025
  • Table 157 : Promega Corp.: Company Snapshot
  • Table 158 : Promega Corp.: Product Portfolio
  • Table 159 : Promega Corp.: News/Key Developments, 2023-2025
  • Table 160 : Qiagen: Company Snapshot
  • Table 161 : Qiagen: Financial Performance, FY 2023 and 2024
  • Table 162 : Qiagen: Product Portfolio
  • Table 163 : Qiagen: News/Key Developments, 2023-2025
  • Table 164 : Revvity: Company Snapshot
  • Table 165 : Revvity: Financial Performance, FY 2023 and 2024
  • Table 166 : Revvity: Product Portfolio
  • Table 167 : Revvity: News/Key Developments, 2023-2025
  • Table 168 : Siemens Healthineers AG: Company Snapshot
  • Table 169 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
  • Table 170 : Siemens Healthineers AG: Product Portfolio
  • Table 171 : Siemens Healthineers AG: Key Developments, 2022-2024
  • Table 172 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 173 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
  • Table 174 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 175 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
  • Table 176 : List of a Few Emerging Startups/Market Disruptors

List of Figures

  • Summary Figure : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
  • Figure 1 : Factors Impacting the Growth of the Biological Imaging Reagent Market, 2024 and 2030
  • Figure 2 : Global Pharmaceutical R&D Spending, by Select Country/Region, 2010-2022
  • Figure 3 : Market Dynamics of Biological and Medical Imaging Reagents
  • Figure 4 : Personalized Medicines' Contribution to Total FDA Approvals, 2015-2023
  • Figure 5 : Number of Patents Documented on Biological and Medical Imaging Reagents, by Leading Applicants, January 2024-May 2024
  • Figure 6 : Patent Shares on Biological and Medical Imaging Reagents, by Jurisdiction, January 2024-May 2025
  • Figure 7 : Patent Shares on Biological and Medical Imaging Reagents, by Type, January 2024-May 2025
  • Figure 8 : Global Market Shares of Biological and Medical Imaging Reagents, by Product Type, 2024
  • Figure 9 : Global Market Shares of Biological and Medical Imaging Reagents, by Modality, 2024
  • Figure 10 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
  • Figure 11 : Global Market Shares of Biological and Medical Imaging Reagents, by Technology, 2024
  • Figure 12 : Global Market Shares of Biological and Medical Imaging Reagents, by End Use, 2024
  • Figure 13 : Global Market Shares of Biological and Medical Imaging Reagents, by Region, 2024
  • Figure 14 : Company Share Analysis of Global Biological and Medical Imaging Reagent Market, 2024
  • Figure 15 : 3C Guidelines for the Handling and Design and of Medical Imaging Agents To Reduce the Pollution and Facilitate Ecologically Friendly Solutions
  • Figure 16 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 17 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 18 : Bayer AG: Revenue Share, by Business Unit, FY 2024
  • Figure 19 : Bayer AG: Revenue Share, by Country/Region, FY 2024
  • Figure 20 : BD: Revenue Share, by Business Unit, FY 2024
  • Figure 21 : BD: Revenue Share, by Country/Region, FY 2024
  • Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
  • Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
  • Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
  • Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
  • Figure 28 : GE HealthCare: Revenue Share, by Business Unit, FY 2024
  • Figure 29 : GE HealthCare: Revenue Share, by Country/Region, FY 2024
  • Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
  • Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
  • Figure 32 : Qiagen: Revenue Share, by Business Unit, FY 2024
  • Figure 33 : Qiagen: Revenue Share, by Country/Region, FY 2024
  • Figure 34 : Revvity: Revenue Share, by Business Unit, FY 2024
  • Figure 35 : Revvity: Revenue Share, by Country/Region, FY 2024
  • Figure 36 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024
  • Figure 37 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024
  • Figure 38 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024